The treatment of age-related macular degeneration poses one of the most significant problems in modern-day ophthalmology. With an aging population this problem will gain even greater weight in the future. EUGENDA was founded to find answers to important questions regarding the development and therapy of age-related macular degeneration.
Funding
We are continuously searching for funding to accommodate our research. If you are interested to provide financial support for our research program, please contact one of the research leaders.
Patients and healthy control individuals
If you have AMD, or if you are above 65 and do not have AMD, and would be interested to participate in our study, please contact us.
News
The EUGENDA database was officially opened on November 30, 2009 in Cologne by Prof. Pinkwart (the Forschungsminister of Nordrhein-Westfalen) and the Dutch politician Mrs. J. Schermers.
